Author

F. Copley

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

A. Rio-Machin· 2 shared J. Fitzgibbon· 2 shared J. Gribben· 2 shared A. Alfonso-Pierola· 1 shared A. Clear· 1 shared A. Diaz-Mazkiaran· 1 shared A. Molero· 1 shared A. Parsons· 1 shared

Activity by Year

2020-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

A. Rio-Machin

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Transcriptional regulation of HSCs in Aging and MDS reveals DDIT3 as a Potential Driver of Dyserythropoiesis

N. Berastegui, M. Ainciburu, J. P. Romero, A. Alfonso-Pierola, C. Philippe, A. Vilas-Zornoza, P. San Martin, R. Ordonez, D. O. Alignani, S. Sarvide, L. Castro, J. M. Lamo-Espinosa, M. San-Julian, T. Jimenez, F. Lopez Cardenas, , F. Prosper

This study identifies DDIT3 as a driver of dyserythropoiesis in MDS by showing its upregulation in HSCs and its ability to disrupt erythropoiesis when overexpressed.

bioRxiv · Sep 8, 2021 · PreprintCancer Biology

CKS1-dependent proteostatic regulation has dual roles combating acute myeloid leukemia whilst protecting normal hematopoiesis

W. Grey, A. Rio-Machin, P. Casado-Izquierdo, J. Miettinen, F. Copley, A. Parsons, C. Heckman, P. Cutillas, J. Gribben, J. Fitzgibbon, D. Bonnet

This study identifies CKS1-dependent proteostasis as a dual target for combating AML while protecting normal hematopoiesis through inhibition of SCFSKP2-CKS1.

bioRxiv · Dec 27, 2020 · PreprintCancer Biology

Co-activation of NF-κB and MYC renders cancer cells addicted to IL6 for survival and phenotypic stability

R. Barbosa, A. Q. Xu, D. D'Andrea, F. Copley, H. Patel, P. Chakravarty, A. Clear, M. Calaminici, M. Janz, B. Zhang, M. Schmidt-Supprian, J. Wang, J. Gribben, R. Tooze, J. Fitzgibbon, , D. P. Calado

This paper shows that co-activation of NF-κB and MYC in cancer cells makes them dependent on IL6 for survival and leads to a poorly-differentiated state similar to human plasmablastic lymphoma and t(8;14)[MYC-IGH] multiple myeloma.

bioRxiv · Apr 12, 2020 · PreprintCancer Biology